$ Value
$0
Shares
300,000
Price
$0
Filed
Apr 28
Insider
Name
GOTTSCHALK ADRIAN
Title
Chief Executive Officer
CIK
0001828724
Roles
Transaction Details
Transaction Date
2025-04-25
Code
G
Table
Non-Derivative
Ownership
Indirect
Equity Swap
No
Shares After
511,704
Footnotes
On April 25, 2025, the Adrian H. Gottschalk Living Trust dated September 8, 2009 (the "Gottschalk Living Trust"), of which the Reporting Person is the trustee, distributed 300,000 shares of the Issuer's Common Stock to the Adrian H. Gottschalk 2025 Grantor Retained Annuity Trust dated April 25, 2025 (the "Gottschalk 2025 GRAT"), of which the Reporting Person is the trustee and sole current beneficiary. | Consists of 47,497 shares held by the Adrian H. Gottschalk 2023 Grantor Retained Annuity Trust dated May 26, 2023, 300,000 shares held by the Gottschalk 2025 GRAT, and 164,207 shares held by the Gottschalk Living Trust.
Filing Info
GOTTSCHALK ADRIAN's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-10 | FHTX | G | $0 |
| 2026-04-10 | FHTX | G | $0 |
| 2026-04-09 | FHTX | G | $0 |
| 2026-04-09 | FHTX | G | $0 |
| 2026-02-05 | FHTX | A | $5.6M |
| 2025-04-25 | FHTX | G | $0 |
| 2025-04-25 | FHTX | G | $0 |
Other Insiders at FHTX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Maynard Ryan D
Chief Financial Officer
|
— | — | 2026-02-23 |
|
Cardama Alfonso Quintas
Chief Medical Officer
|
— | — | 2026-01-30 |
|
GOTTSCHALK ADRIAN
Chief Executive Officer
|
— | — | 2026-04-10 |
|
Bellon Steven F.
Chief Scientific Officer
|
— | — | 2026-01-30 |
|
LaCascia Michael
Chief Legal Officer
|
— | — | 2026-01-30 |
|
Costa Carlos
Chief People Officer
|
— | — | 2026-01-30 |
|
Rivkin Anna
Chief Business Officer
|
— | — | 2026-01-30 |